BCAX
Price
$14.24
Change
-$0.67 (-4.49%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
780.09M
Intraday BUY SELL Signals
VYGR
Price
$3.98
Change
-$0.27 (-6.35%)
Updated
Nov 13 closing price
Capitalization
221.29M
116 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAX vs VYGR

Header iconBCAX vs VYGR Comparison
Open Charts BCAX vs VYGRBanner chart's image
Bicara Therapeutics
Price$14.24
Change-$0.67 (-4.49%)
Volume$13.94K
Capitalization780.09M
Voyager Therapeutics
Price$3.98
Change-$0.27 (-6.35%)
Volume$457.1K
Capitalization221.29M
BCAX vs VYGR Comparison Chart in %
BCAX
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BCAX vs. VYGR commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAX is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BCAX: $14.26 vs. VYGR: $3.98)
Brand notoriety: BCAX and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAX: 63% vs. VYGR: 67%
Market capitalization -- BCAX: $780.09M vs. VYGR: $221.29M
BCAX [@Biotechnology] is valued at $780.09M. VYGR’s [@Biotechnology] market capitalization is $221.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAX’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • BCAX’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCAX and VYGR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAX’s TA Score shows that 3 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • BCAX’s TA Score: 3 bullish, 7 bearish.
  • VYGR’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than BCAX.

Price Growth

BCAX (@Biotechnology) experienced а -2.13% price change this week, while VYGR (@Biotechnology) price change was -5.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCAX($780M) has a higher market cap than VYGR($221M). VYGR has higher P/E ratio than BCAX: VYGR (6.00) vs BCAX (2.65). BCAX YTD gains are higher at: -14.409 vs. VYGR (-25.044). VYGR (-119.18M) and BCAX (-121M) have comparable annual earnings (EBITDA) . BCAX has more cash in the bank: 437M vs. VYGR (43.9M). BCAX has less debt than VYGR: BCAX (2.24M) vs VYGR (40.2M). VYGR has higher revenues than BCAX: VYGR (42.6M) vs BCAX (0).
BCAXVYGRBCAX / VYGR
Capitalization780M221M353%
EBITDA-121M-119.18M102%
Gain YTD-14.409-25.04458%
P/E Ratio2.656.0044%
Revenue042.6M-
Total Cash437M43.9M995%
Total Debt2.24M40.2M6%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCAXVYGR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BCAX
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVRMX26.000.18
+0.70%
Franklin Mutual Small-Mid Cap Val Adv
TGIHX17.120.03
+0.18%
Nuveen Core Equity I
PXQSX24.020.04
+0.17%
Virtus KAR Small-Cap Value I
DIFEX12.53N/A
N/A
MFS Diversified Income R2
CLPCX13.78-0.01
-0.07%
Catalyst Nasdaq-100 Hedged Equity C

BCAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAX has been loosely correlated with IMNM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAX
1D Price
Change %
BCAX100%
+1.22%
IMNM - BCAX
42%
Loosely correlated
-0.51%
SYRE - BCAX
41%
Loosely correlated
+0.34%
TIL - BCAX
39%
Loosely correlated
-4.83%
VYGR - BCAX
39%
Loosely correlated
-0.23%
XENE - BCAX
39%
Loosely correlated
-0.60%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.23%
RGNX - VYGR
54%
Loosely correlated
+0.43%
IMTX - VYGR
53%
Loosely correlated
+16.10%
KYMR - VYGR
52%
Loosely correlated
+0.25%
IMNM - VYGR
52%
Loosely correlated
-0.51%
XNCR - VYGR
51%
Loosely correlated
-3.23%
More